164 related articles for article (PubMed ID: 12608149)
1. Changes in ATP III focus on diabetes and the metabolic syndrome.
Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():1, 6. PubMed ID: 12608149
[No Abstract] [Full Text] [Related]
2. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic dyslipidemia in the cardiometabolic syndrome.
Govindarajan G; Chowdhury N; Flaker G
J Cardiometab Syndr; 2006; 1(2):153-5. PubMed ID: 17679818
[No Abstract] [Full Text] [Related]
4. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
Brunzell JD; Ayyobi AF
Am J Med; 2003 Dec; 115 Suppl 8A():24S-28S. PubMed ID: 14678862
[TBL] [Abstract][Full Text] [Related]
5. Is this the worst outcome of metabolic syndrome? Hypophosphatemia and resulting cardiac arrest during the treatment of diabetic ketoacidosis with hypertriglyceridemia.
Osuka A; Matsuoka T; Idoguchi K
Intern Med; 2009; 48(16):1391-5. PubMed ID: 19687585
[TBL] [Abstract][Full Text] [Related]
6. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
[TBL] [Abstract][Full Text] [Related]
7. Triglycerides and coronary artery disease.
Sum CF; Tan CE; Wang KW
Singapore Med J; 1992 Oct; 33(5):443-5. PubMed ID: 1455264
[No Abstract] [Full Text] [Related]
8. [Consensus concerning triglycerides and high-density lipoprotein-cholesterol in the United States].
Gevers Leuven JA
Ned Tijdschr Geneeskd; 1992 Sep; 136(39):1891-3. PubMed ID: 1407159
[No Abstract] [Full Text] [Related]
9. Non-high-density lipoprotein cholesterol: the forgotten therapeutic target.
Maki KC; Galant R; Davidson MH
Am J Cardiol; 2005 Nov; 96(9A):59K-64K; discussion 34K-35K. PubMed ID: 16291016
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
Khan SR; Ayub N; Nawab S; Shamsi TS
J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of dyslipidemias and its benefits].
Taskinen MR
Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
[No Abstract] [Full Text] [Related]
12. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
14. Management of dyslipidemia in the metabolic syndrome.
Tan KC
Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):99-108. PubMed ID: 17584044
[TBL] [Abstract][Full Text] [Related]
15. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
Rankin FM; Cohen JD
J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
[No Abstract] [Full Text] [Related]
16. Diabetes and coronary heart disease: the role of hyperlipidemia.
Betteridge DJ
J Diabet Complications; 1990; 4(2):53-6. PubMed ID: 2145299
[No Abstract] [Full Text] [Related]
17. [Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
Demant T
Fortschr Med Orig; 2001; 119(1):37-40. PubMed ID: 11935656
[TBL] [Abstract][Full Text] [Related]
18. Coronary risk and dyslipidemia in type 2 diabetic patients.
Udawat H; Goyal RK; Maheshwari S
J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
[TBL] [Abstract][Full Text] [Related]
19. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease?
Després JP
CMAJ; 1993 Apr; 148(8):1339-40. PubMed ID: 8462056
[No Abstract] [Full Text] [Related]
20. [Correlation between atherosclerosis--coronary disease and insulin resistance, regarded as the basis of metabolic syndrome].
Mihalcea C; Pandele GI
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):59-68. PubMed ID: 20509277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
